UFP Technologies, Inc.
NASDAQ:UFPTMedical - Devices
+$10.10 today
- Market cap
- $2.37B
- Beta
- 1.10
- P/E (TTM)
- 26.8
- EPS (TTM)
- $8.89
Volume 0.08M
Average 0.21M
UFPT EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
UFP Technologies, Inc.NASDAQ: UFPT
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $33.1M rose 14.1% year over year, ahead of the +3.1% change in trailing-twelve-month EBITDA. Sequentially, it rose 17.2% from the prior quarter. Over 3 fiscal years it compounded at +18.3% a year.
Context
- EBITDA amounted to 18.5% of revenue in FY2025, down 0.5 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $121.57M (+9.1%) for the fiscal year ending Dec 2026, a slowdown from the +16.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $33.1M+17.2% QoQ
- Last fiscal yearDec 2025
- $111.47M+16.4% YoY
- LTMJun 2026
- $116.08M+3.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +14.1% | +8.0% | -6.0 pp |
| 1 year | +16.4% | +9.1% | -7.3 pp |
| 3-year CAGR | +18.3% | +11.3% | -6.9 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 111.47M USD
- Year-over-year change
- +16.4%
- 4-year CAGR
- +39.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 111.47M | +16.4% |
| FY2024 | 2024-12-31 | 95.8M | +38.9% |
| FY2023 | 2023-12-31 | 68.95M | +2.4% |
| FY2022 | 2022-12-31 | 67.37M | +127.2% |
| FY2021 | 2021-12-31 | 29.65M | — |
EBITDA vs competitors
How UFPT compares with its peers on the latest reported figures
- UFPT's LTM Jun 2026 EBITDA of $116.08M is the 4th highest of the 11 companies compared; the peer median is -$6.31M.
- Its year-over-year change of +3.1% is the 6th highest of 11, against a peer median of -5.0%.
- EBITDA amounts to 18.4% of revenue for UFPT, versus a peer median of 13.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $10.27B | +9.8% | +4.1% | 27.3% | |
| LTM Jun 2026 | $3.07B | -19.7% | +6.1% | 15.2% | |
| LTM Mar 2026 | $169.63M | -31.6% | +170.6% | 12.4% | |
| LTM Jun 2026 | $116.08M | +3.1% | +18.3% | 18.4% | |
| LTM Mar 2026 | -$3.71M | +78.9% | — | 7.7% | |
| LTM Mar 2026 | -$5.99M | +68.1% | — | 2.9% | |
| LTM Mar 2026 | -$6.63M | +50.3% | — | 2.7% | |
| LTM Sep 2026 | -$10.54M | +78.0% | — | 4.0% | |
| LTM Mar 2026 | -$43.24M | -86.4% | — | 33.9% | |
| LTM Mar 2026 | -$289.3M | -260.5% | — | 17.6% | |
| LTM Apr 2026 | -$748.33M | -58.6% | — | 32.8% | |
| Peer median (excluding UFPT) | -$6.31M | -5.0% | +6.1% | 13.8% | |
Competitors are the stored peer set for UFPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 206.32M | 353.79M | 400.07M | 504.42M | 602.8M |
| Cost of Revenue | 155.21M | 263.53M | 287.85M | 357.73M | 432.39M |
| Gross Profit | 51.11M | 90.26M | 112.23M | 146.69M | 170.41M |
| Gross Margin | 24.8% | 25.5% | 28.1% | 29.1% | 28.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 29.48M | 45.8M | 50.89M | 62.22M | 77.44M |
| Operating Expenses | 29.9M | 34.86M | 54.56M | 65.8M | 78.07M |
| Depreciation & Amortization | 8.41M | 11.89M | 11.41M | 14.72M | 19.15M |
| EBITDA | 29.65M | 67.37M | 68.95M | 95.8M | 111.47M |
| EBITDA Margin | 14.4% | 19.0% | 17.2% | 19.0% | 18.5% |
| Operating Income | 21.22M | 55.4M | 57.66M | 80.9M | 92.34M |
| Operating Margin | 10.3% | 15.7% | 14.4% | 16.0% | 15.3% |
| Interest Income | 49K | 0 | 0 | 0 | 0 |
| Interest Expense | 39K | 2.76M | 3.65M | 8.06M | 9.8M |
| Other Income / Expenses | (13K) | (2.68M) | (3.76M) | (7.87M) | (9.83M) |
| Income Before Tax | 21.21M | 52.72M | 53.9M | 73.03M | 82.51M |
| Pre-Tax Margin | 10.3% | 14.9% | 13.5% | 14.5% | 13.7% |
| Income Tax Expense | 5.32M | 10.93M | 8.98M | 14.04M | 14.2M |
| Net Income | 15.89M | 41.79M | 44.92M | 58.98M | 68.31M |
| Net Margin | 7.7% | 11.8% | 11.2% | 11.7% | 11.3% |
| EPS (Basic) | 2.11 | 5.52 | 5.89 | 7.69 | 8.87 |
| EPS (Diluted) | 2.09 | 5.45 | 5.83 | 7.58 | 8.77 |
| Weighted Avg Shares | 7.52M | 7.56M | 7.62M | 7.67M | 7.71M |
| Weighted Avg Shares (Diluted) | 7.62M | 7.66M | 7.7M | 7.79M | 7.8M |
UFP Technologies, Inc.
NASDAQ:UFPT
Intrinsic Alpha fair value
Locked
Current Price
$305.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.